While surgery and chemo- and radiotherapy interventions continue to represent essential treatments in CRC management, depending on the tumor stage, the experimental evidence reported herein strongly indicates Gal-3 targeting by natural food compounds as a potential intervention strategy, with important implications in the therapeutic management of CRC patients. Here, LGALS3 is linked to colorectal carcinoma.